GLAESNER WOLFGANG INDIANAPOLIS,MICANOVIC RADMILLA INDIANAPOLIS,TSCHANG SHENG-HUNG RAINBOW CARMEL
申请号：
HU0302529
公开号：
HU229218B1
申请日:
2001.11.29
申请国别(地区):
HU
年份:
2013
代理人:
摘要：
The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the in vivo half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.
